<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<?OntoDPSData docID="3374034" markupID="2092790" OntoTechnologyVersion="3.59.92.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:BasicEntity="http://www.abbyy.com/ns/BasicEntity#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:Aux="http://www.abbyy.com/ns/Aux#">
	<BasicEntity:MoneySimplified rdf:nodeID="bnodeABADA1DD-8718-47CC-861F-EBDB46B6C97C">
		<BasicEntity:ms_major_currency xml:lang="en-US">krona</BasicEntity:ms_major_currency>
		<BasicEntity:ms_major_amount xml:lang="en-US">1</BasicEntity:ms_major_amount>
	</BasicEntity:MoneySimplified>
	<Aux:TextAnnotations rdf:nodeID="bnode2BC43622-73F1-4C6D-8DF2-C84D7448AE0D">
		<Aux:document_text xml:lang="en-US">In 1918, dye-producer AB Svensk färgämnesindustri (ASF) bought Astra. ASF planned to create a large Swedish chemical group rivaling those in continental Europe. However, ASF was unsuccessful, and the company soon had large financial problems and was liquidated in 1920. Astra was bailed out and acquired by the Swedish government through its monopoly liquor-producing company Vin- och spritcentralen, with the intention to form a national monopoly for pharmaceutical production. These plans met with resistance, and therefore a Swedish merchant, Erik Kistner, formed a consortium which bought debt-ridden Astra back from the government for a symbolic price of one krona. The consortium included banker Jacob Wallenberg, and the Wallenberg family since continued to have a stake in the company. Under long-serving CEO Börje Gabrielsson, who led the company until 1957, Astra showed profit from 1929 and grew continuously. In the 1930s, Astra started to conduct its own research, initially on a very small scale, rather than just manufacturing existing pharmaceutical preparations. The sulfa drug Sulfathiazole was one of the results of these research activities. The company Tika was acquired in 1939, and the pharmaceutical factories of Paul G. Nordström in Hässleholm (later renamed to Hässle, and operated as a division of Astra) in 1942. This established Astra as the leading Swedish pharmaceutical company.</Aux:document_text>
		<Aux:annotation>
			<Aux:InstanceAnnotation rdf:nodeID="bnode65973A5A-2A19-4A60-AA97-D98084BF0C29">
				<Aux:annotation_start rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">660</Aux:annotation_start>
				<Aux:annotation_end rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">669</Aux:annotation_end>
				<Aux:instance rdf:nodeID="bnodeABADA1DD-8718-47CC-861F-EBDB46B6C97C"/>
			</Aux:InstanceAnnotation>
		</Aux:annotation>
		<Aux:annotation>
			<Aux:PropertyAnnotation rdf:nodeID="bnode5803CBCB-C951-4796-9D7F-EF54A05EF1D4">
				<Aux:annotation_start rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">660</Aux:annotation_start>
				<Aux:annotation_end rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">663</Aux:annotation_end>
				<Aux:instance rdf:nodeID="bnodeABADA1DD-8718-47CC-861F-EBDB46B6C97C"/>
				<Aux:property_name xml:lang="en-US">http://www.abbyy.com/ns/BasicEntity#ms_major_amount</Aux:property_name>
				<Aux:property_value xml:lang="en-US">1</Aux:property_value>
			</Aux:PropertyAnnotation>
		</Aux:annotation>
		<Aux:annotation>
			<Aux:PropertyAnnotation rdf:nodeID="bnode29E86216-DECF-47C2-B586-23AD789D1A47">
				<Aux:annotation_start rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">664</Aux:annotation_start>
				<Aux:annotation_end rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">669</Aux:annotation_end>
				<Aux:instance rdf:nodeID="bnodeABADA1DD-8718-47CC-861F-EBDB46B6C97C"/>
				<Aux:property_name xml:lang="en-US">http://www.abbyy.com/ns/BasicEntity#ms_major_currency</Aux:property_name>
				<Aux:property_value xml:lang="en-US">krona</Aux:property_value>
			</Aux:PropertyAnnotation>
		</Aux:annotation>
	</Aux:TextAnnotations>
</rdf:RDF>